
Amgen Announces First Quarter 2025 Financial Performance
Amgen Posts Strong First Quarter 2025 Financial Results, Driven by Robust Product Demand and Strategic Launches Amgen Inc. (NASDAQ: AMGN) reported its financial results for the first quarter of 2025, showcasing solid performance across its global portfolio. The biotechnology giant…